San Diego Cancer Center
Vista, California, United States
Cancer treatment center in Vista, California
910 Sycamore Ave, Vista, CA 92081
About San Diego Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Cephalon
2
Translational Oncology Research International
2
Bristol-Myers Squibb
1
Cell Genesys
1
Chiron Corporation
1
Novacea
1
Novartis
1
Novartis Pharmaceuticals
1
Clinical Trials at San Diego Cancer Center
During the past decade, San Diego Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
2002-08-01
2005-12-01
Unknown status
250
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
Completed
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
2003-01-01
2007-01-01
Completed
855
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
2003-02-01
Completed
1,168
Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma
2003-09-01
2007-04-01
Completed
72
SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
2004-04-01
2008-03-01
Completed
66
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
2004-07-01
2008-10-01
Terminated
626
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
2004-09-01
2009-10-01
Completed
1,783
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "San Diego Cancer Center" #1 sponsor was "Cephalon" with 2 trials, followed by "Translational Oncology Research International" with 2 trials
sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Cell Genesys" with 1 trials sponsored and "Chiron Corporation"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "San Diego Cancer Center"
#1 collaborator was "Bayer" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Aventis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at San Diego Cancer Center
According to Clinical.Site data, the most researched conditions in "San Diego Cancer Center" are
"Prostate Cancer" (3 trials), "Colonic Neoplasms" (2 trials), "Colorectal Neoplasms" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials) and "Rectal Neoplasms" (2 trials). Many other conditions were trialed in "San Diego Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at San Diego Cancer Center
Most popular intervention types in "San Diego Cancer Center" are "Drug" (10 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Vatalanib" (2 trials), "Bevacizumab (drug), Herceptin (drug)" (1 trials), "Chemotherapy (Taxotere and prednisone)" (1 trials), "Erlotinib + Bevacizumab" (1 trials) and "Immunotherapy with allogeneic prostate vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at San Diego Cancer Center
The vast majority of trials in "San Diego Cancer Center" are
6 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at San Diego Cancer Center
Currently, there are NaN active trials in "San Diego Cancer Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in San Diego Cancer Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in San Diego Cancer Center, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".